Petros Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Petros Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2024.
  • Petros Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $154K, a 47.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $154K -$141K -47.8% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $191K -$136K -41.7% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $226K -$132K -36.9% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $261K -$128K -33% Sep 30, 2023 10-Q 2023-11-15
Q2 2023 $294K -$124K -29.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $327K -$121K -27% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $358K -$117K -24.6% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $389K -$114K -22.6% Sep 30, 2022 10-Q/A 2022-11-15
Q2 2022 $419K -$110K -20.8% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $448K -$107K -19.3% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $476K -$104K -17.9% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $503K Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $529K Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $554K Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $580K Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.